Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Costs and expenses    
Operating costs $ 2,130 $ 1,683
Research and development 547 348
Selling, general and administrative 7,624 1,238
Total operating costs and expenses 10,301 3,269
Interest expense 6,089 588
Change in fair value of warrants 13,621 655
Other expense 109 52
Total other expense 19,819 1,295
Net loss $ (30,120) $ (4,564)
Loss per share    
Basic (in usd per share) $ (0.59) $ (0.19)
Diluted (in usd per share) $ (0.59) $ (0.19)
Weighted average common shares    
Basic (in shares) 51,223 27,156
Diluted (in shares) 51,223 27,156